Literature DB >> 24777943

Respiratory muscle function in infants with spinal muscular atrophy type I.

Richard S Finkel1, Daniel J Weiner, Oscar H Mayer, Joseph M McDonough, Howard B Panitch.   

Abstract

OBJECTIVE: To determine the feasibility and safety of respiratory muscle function testing in weak infants with a progressive neuromuscular disorder. RATIONALE: Respiratory insufficiency is the major cause of morbidity and mortality in infants with spinal muscular atrophy type I (SMA-I). HYPOTHESIS: Tests of respiratory muscle strength, endurance, and breathing patterns can be performed safely in SMA-I infants. Useful data can be collected which parallels the clinical course of pulmonary function in SMA-I. STUDY DESIGN AND SUBJECT SELECTION: An exploratory study of respiratory muscle function testing and breathing patterns in seven infants with SMA-I seen in our neuromuscular clinic. Measurements were made at initial study visit and, where possible, longitudinally over time.
METHODOLOGY: We measured maximal inspiratory (MIP) and transdiaphragmatic pressures, mean transdiaphragmatic pressure, airway occlusion pressure at 100 msec of inspiration, inspiratory and total respiratory cycle time, and aspects of relative thoracoabdominal motion using respiratory inductive plethysmography (RIP). The tension time index of the diaphragm and of the respiratory muscles, phase angle (Φ), phase relation during the total breath, and labored breathing index were calculated.
RESULTS: Age at baseline study was 54-237 (median 131) days. Reliable data were obtained safely for MIP, phase angle, labored breathing index, and the invasive and non-invasive tension time indices, even in very weak infants. Data obtained corresponded to the clinical estimate of severity and predicted the need for respiratory support.
CONCLUSIONS: The testing employed was both safe and feasible. Measurements of MIP and RIP are easily performed tests that are well tolerated and provide clinically useful information for infants with SMA-I.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  maximal inspiratory pressure; neuromuscular weakness; respiratory inductive plethysmography; tension time index

Mesh:

Year:  2014        PMID: 24777943     DOI: 10.1002/ppul.22997

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

Review 1.  Spinal Muscular Atrophy.

Authors:  Stephen J Kolb; John T Kissel
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

2.  Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.

Authors:  Kevin A Strauss; Michelle A Farrar; Francesco Muntoni; Kayoko Saito; Jerry R Mendell; Laurent Servais; Hugh J McMillan; Richard S Finkel; Kathryn J Swoboda; Jennifer M Kwon; Craig M Zaidman; Claudia A Chiriboga; Susan T Iannaccone; Jena M Krueger; Julie A Parsons; Perry B Shieh; Sarah Kavanagh; Sitra Tauscher-Wisniewski; Bryan E McGill; Thomas A Macek
Journal:  Nat Med       Date:  2022-06-17       Impact factor: 87.241

3.  New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy.

Authors:  Zhidai Liu; Penghui Zhang; Xiaoyan He; Shan Liu; Shi Tang; Rong Zhang; Xinbin Wang; Junjie Tan; Bin Peng; Li Jiang; Siqi Hong; Lin Zou
Journal:  BMC Neurol       Date:  2016-08-17       Impact factor: 2.474

4.  Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA).

Authors:  A LoMauro; A Aliverti; C Mastella; M T Arnoldi; P Banfi; G Baranello
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240

5.  Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study.

Authors:  Federica Trucco; Deborah Ridout; Mariacristina Scoto; Giorgia Coratti; Marion L Main; Robert Muni Lofra; Anna G Mayhew; Jacqueline Montes; Marika Pane; Valeria Sansone; Emilio Albamonte; Adele D'Amico; Enrico Bertini; Sonia Messina; Claudio Bruno; Deepak Parasuraman; Anne-Marie Childs; Vasantha Gowda; Tracey Willis; Min Ong; Chiara Marini-Bettolo; Darryl C De Vivo; Basil T Darras; John Day; Elizabeth A Kichula; Oscar H Mayer; Aledie A Navas Nazario; Richard S Finkel; Eugenio Mercuri; Francesco Muntoni
Journal:  Neurology       Date:  2020-10-16       Impact factor: 9.910

Review 6.  The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Kirellos Said Abbas; Mennatullah Mohamed Eltaras; Nahla Ahmed El-Shahat; Basel Abdelazeem; Mahmoud Shaqfeh; James Robert Brašić
Journal:  Medicina (Kaunas)       Date:  2022-02-01       Impact factor: 2.430

Review 7.  Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy.

Authors:  Min Yang; Hiroyuki Awano; Satoru Tanaka; Walter Toro; Su Zhang; Omar Dabbous; Ataru Igarashi
Journal:  Adv Ther       Date:  2022-03-20       Impact factor: 4.070

8.  A New Method for Measuring Bell-Shaped Chest Induced by Impaired Ribcage Muscles in Spinal Muscular Atrophy Children.

Authors:  Antonella LoMauro; Paolo Banfi; Chiara Mastella; Katia Alberti; Giovanni Baranello; Andrea Aliverti
Journal:  Front Neurol       Date:  2018-09-13       Impact factor: 4.003

Review 9.  Dysphagia Phenotypes in Spinal Muscular Atrophy: The Past, Present, and Promise for the Future.

Authors:  Katlyn Elizabeth McGrattan; Robert J Graham; Christine J DiDonato; Basil T Darras
Journal:  Am J Speech Lang Pathol       Date:  2021-04-06       Impact factor: 2.408

10.  Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy.

Authors:  Giovanni Baranello; Ksenija Gorni; Monica Daigl; Anna Kotzeva; Rachel Evans; Neil Hawkins; David A Scott; Anadi Mahajan; Francesco Muntoni; Laurent Servais
Journal:  Clin Pharmacol Ther       Date:  2021-06-05       Impact factor: 6.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.